Kevin Lam
Biographic Data
| ID | 3603439 |
|---|---|
| NAME | Kevin Lam |
| GIVEN NAMES | Kevin |
| FAMILY NAME | Lam |
| SIGNATURE | LAM K |
| AFFILIATIONS | Rutgers, the State University of New Jersey |
| ORCID | 0000-0002-1535-7059 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Assessing readiness for implementation of psychedelic-assisted mental health therapy, in low- and middle-income countries
Mental health disorders (MHD) rank among the top 10 global causes of disease burden, with significant economic and social costs. Current treatments often have limited efficacy or tolerability, and there has been little recent innovation in treatments. In the past decade, clinical research on Psychedelic-Assisted Therapies (PAT) for treating MHD has increased in high-income countries, while most MHD burdens are in low and middle-income countries. …
Validation of the English and Mandarin versions of the Fear of Cancer Recurrence Inventory in an Asian population
The Fear of Cancer Recurrence Inventory has shown adequate psychometric properties to assess for fear of cancer recurrence among cancer survivors. However, the use of the Fear of Cancer Recurrence Inventory in Asia is limited due to the paucity of validation studies. Participants include 331 cancer survivors who completed the English and newly developed Mandarin versions of the Fear of Cancer Recurrence Inventory. The results revealed that both v…
No prominent works on this page.
Validation of the English and Mandarin versions of the Fear of Cancer Recurrence Inventory in an Asian population
The Fear of Cancer Recurrence Inventory has shown adequate psychometric properties to assess for fear of cancer recurrence among cancer survivors. However, the use of the Fear of Cancer Recurrence Inventory in Asia is limited due to the paucity of validation studies. Participants include 331 cancer survivors who completed the English and newly developed Mandarin versions of the Fear of Cancer Recurrence Inventory. The results revealed that both v…
Assessing readiness for implementation of psychedelic-assisted mental health therapy, in low- and middle-income countries
Mental health disorders (MHD) rank among the top 10 global causes of disease burden, with significant economic and social costs. Current treatments often have limited efficacy or tolerability, and there has been little recent innovation in treatments. In the past decade, clinical research on Psychedelic-Assisted Therapies (PAT) for treating MHD has increased in high-income countries, while most MHD burdens are in low and middle-income countries. …
Psychology (2 works) · Cancer (1 works) · Cancer recurrence (1 works) · Cancer survivorship and care (1 works) · Chemical synthesis and alkaloids (1 works) · Childhood Cancer Survivors' Quality of Life (1 works) · Clinical Psychology (1 works) · Concurrent validity (1 works) · Confirmatory factor analysis (1 works) · Developing country (1 works)